Short-course multi-drug therapy for leprosy patients

Area of Science:

• Dermatology
• Infectious Diseases
• Public Health

Background:

• Leprosy remains a significant global health concern.
• Short-course multi-drug therapy (MDT) is the standard treatment for leprosy.
• Evaluating the effectiveness and safety of MDT is crucial for disease control.

Purpose of the Study:

• To assess the effectiveness, recurrence rates, and side effects of short-course MDT for leprosy patients.
• To determine the optimal duration of MDT for paucibacillary leprosy.
• To evaluate the feasibility of MDT in a real-world setting, considering patient adherence.

Main Methods:

• A cohort of 108 leprosy patients receiving short-course MDT was studied.
• Data collected included treatment completion rates, clinical and histopathological outcomes, recurrence, and adverse events.
• Patient adherence and reasons for default were also recorded.

Main Results:

• A significant proportion of patients (48.1%) defaulted from treatment.
• MDT demonstrated high effectiveness in controlling leprosy, with 83% of paucibacillary patients completing treatment in 6 months.
• Recurrence rates in paucibacillary patients were low (2.3%), and side effects were observed in 5.4% of patients. Leprosy reactions occurred in two patients.

Conclusions:

• Short-course MDT is effective in controlling leprosy, particularly for paucibacillary cases.
• While adherence remains a challenge, the regimen shows a favorable safety profile and low recurrence rates.
• Further evaluation is needed for multibacillary leprosy due to the limited sample size in this study.